Who is sponsoring NCT04519762?

NCT04519762 is sponsored by Ain Shams University.

What drugs are being tested in NCT04519762?

Interventions in NCT04519762: Glycophos (Sodium Glycerophosphate), Antibiotics, Inotropes.

What condition does NCT04519762 study?

NCT04519762 studies Hypophosphatemia.

Is NCT04519762 still recruiting?

NCT04519762 is currently status unknown. Last updated 20 August 2020.

Last reviewed 2020-08-20 · How we verify

NCT04519762

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICU

Status unknown Phase 4 Last updated 20 August 2020

What this trial tests

Phase 4 trial testing Glycophos (Sodium Glycerophosphate) in Hypophosphatemia in 100 participants. Status unknown.

Timeline

15 September 2020

Primary endpoint
15 December 2020

15 December 2020

Quick facts

Lead sponsor	Ain Shams University
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	100
Start date	15 September 2020
Primary completion	15 December 2020
Estimated completion	15 December 2020

Drugs / interventions tested

Glycophos (Sodium Glycerophosphate) — full drug profile →
Antibiotics — full drug profile →
Inotropes — full drug profile →

Conditions studied

Hypophosphatemia — all drugs for Hypophosphatemia →

Sponsor

Ain Shams University

Who can join

Adults 18 to 70, any sex, with Hypophosphatemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study aimed to determine the incidence of hypophosphatemia (HP) among severe sepsis/septic shock patients admitted to ICU and its impact on morbidity and mortality rates of these patients, and to evaluate the impact of phosphorous supplemental therapy (PST) on such outcomes.Thus, this study will hypothesize that diagnosis and management of HP may be advantageous for reduction of morbidity and mortality rates of septic patients admitted to ICU.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prognostic value of serum phosphate levels in sepsis: a systematic review and meta-analysis.
Wei S, Li Y, Zhang C, Guo X, et al · · 2023 · cited 10× · PMID 37849826 · DOI 10.7717/peerj.16241

Verify or expand the search:

Other recruiting trials for Hypophosphatemia

Currently open trials in the same condition.

NCT07233889 — Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of H · NA · recruiting
NCT06754670 — Effect of Hypophosphatemia on Neuro-excursion Efficiency During Mechanical Ventilator Weaning · recruiting
NCT06112236 — Effects of Treatments for Anemia and Iron Deficiency on the Electrolyte Balance in Lung Transplant Recipients: A Special · active not recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04519762 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 20 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04519762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing